Study Design. A retrospective cohort.
C ervical spondylotic myelopathy (CSM) is the most common acquired cause of spinal cord dysfunction in people over the age of 55. 1 It is a slowly progressive disorder usually caused by spinal cord compression and ischemia due to age-related changes in the spine, and is characterized by neck pain, radicular arm pain, paresthesia, weakness, and gait spasticity. Progression usually occurs in a stepwise pattern but approximately 5% of cases decline rapidly, and prognosis of nonoperative treatment is poor once the patient is frankly myelopathic. The objective of surgery is to decompress the spinal cord. [2] [3] [4] Several studies have attempted to describe the prognostic significance of preoperative symptom duration. Some studies have found no association with outcomes, [5] [6] [7] but most studies have concluded that the duration of symptoms is a significant prognostic variable. Many of these studies specify that duration of symptoms is significant beyond particular time points, typically of 12 [8] [9] [10] [11] [12] or 24 months. 13, 14 At least two review studies have found low evidence for the influence of symptom duration on postoperative outcomes. 15, 16 It is well established that cigarette smoking is generally associated with poor prognosis. Numerous studies have demonstrated that smoking is associated with decreased bone density, increased risk of fracture, 17 -21 increased healing time for fractures, 22 and increased failure rate of lumbar surgeries. 23 -26 However, only a handful of studies have evaluated the impact of smoking on cervical surgery, and the results from these are equivocal. We have recently described the negative influence of smoking on postoperative recovery for cervical myelopathy. 27 However, to our knowledge, there is no research that focuses specifically on the interplay between smoking status and duration of symptoms in terms of outcomes as measured by the Nurick score. The present study is our attempt to clarify this relationship.
MATERIALS AND METHODS
The Institutional Review Board approval was obtained. The medical records of all consecutive patients who underwent surgery for CSM by the senior author between March 2005 and July 2012 were reviewed. All surgeries were performed at University Hospital or the Veterans Administration Hospital. CSM was diagnosed by the presence of upper motor neuron signs, clonus, gait abnormalities, or difficulty with fine motor movements such as buttoning a shirt. Nurick score (Table 1) 28 was assessed at presentation and at followup and was the only outcome measure recorded in this cohort. Inclusion criteria were the diagnosis of CSM with a Nurick score, surgical intervention, and at least 2 years follow-up. Smoking history including number cigarettes smoked daily and number of years of smoking was obtained from the electronic medical record, which contained data collected from intake forms given to all patients at the initial visit. Approximate duration of symptoms was also recorded at the initial visit. Age at presentation, sex, preoperative Nurick score, postoperative Nurick score, duration of symptoms preoperatively, duration of follow-up, procedure performed, approach (anterior vs. posterior vs. anterior and posterior), prior surgery, number of levels fused, diabetes status, cocaine use, ethanol use, signal change on preoperative magnetic resonance imaging (MRI), and whether the patient was cared for by the Veteran's Health Administration or was privately insured were recorded. All patients with a signal change were determined to have moderate to severe signal change as reported by a radiologist. Patients were stratified according to symptom duration (6, 12, or 24 months) and smoking history. Analysis was done with ordered logistic regression analysis using statistical software (StataCorp, College Station, TX). Results are reported with the logit regression coefficient and odds ratios (ORs). The ordered logit regression coefficient represents the change in the ordered logodds of being in a higher category of the independent variable (Nurick change) when all other variables are held constant. The ORs (also called proportional ORs) are obtained by exponentiating the coefficients. The proportional OR indicates the odds of having a higher category of Nurick change versus lower categories for each unit increase in the dependent variable, with all others held constant.
Surgical Technique
Patients were evaluated with complete neurological examination and Nurick scores preoperatively and postoperatively at 6 weeks, 3 months, 6 months, 1 year, and annually thereafter. Decompression procedures performed included single or multilevel corpectomy, anterior decompression with strut grafting and instrumentation, posterior cervical laminoplasty, and posterior cervical laminectomy and fusion. Patients were placed in a Miami J collar (Ossure, Foothill Ranch, CA) postoperatively and sent to physical and occupational therapy when able. All procedures were performed by the senior author with the assistance of residents and fellows.
RESULTS
Of the 125 patients who met inclusion criteria, 44 were female and 81 were male. Eighty were nonsmokers and 45 were smokers. Average follow-up was 31.3 months (Stdev 13.48). The average age of all patients was 55.16 years (range 27-89 yrs) and there was no difference in age according to gender (55.02 for females vs. 55.23 for males), but smokers were younger than nonsmokers (57.5 vs. 51.0 yrs, P ¼ 0.014). Smokers also had a longer but statistically insignificant average duration of preoperative symptoms (26.8 vs. 20.6 mo, P ¼ 0.28). The median preoperative Nurick score for all patients was 2. Ordered logit analysis revealed no statistically significant influence of age, gender, duration of symptoms, or tobacco use on the preoperative Nurick score (P > 0.05). The median improvement in Nurick score for all patients was 1. Patients with fewer than 12 months of symptoms before surgery had a median improvement in Nurick score of 2 compared with 1 for those with greater than 12 months of symptoms. Similarly, the median change in Nurick score for smokers was 1 compared with 2 in nonsmokers.
Ordered logit analysis was done to assess the influence of symptom duration and tobacco use on change in Nurick score. Age, gender, diabetes, cocaine use, alcohol use, tobacco use, signal change on preoperative MRI, severity of myelopathy, total levels fused, prior surgery, and surgical procedure were included in the model. Analysis of all Table 2 .
DISCUSSION
Several studies have attempted to describe the prognostic significance of preoperative symptom duration on surgical outcomes in patients with CSM. The majority of studies support the notion that a longer duration of symptoms adversely affects outcomes, but some authors disagree. For example, Naderi et al. 6 concluded in a retrospective study of 27 patients that there is no correlation as assessed by The Modified Japanese Orthopaedic Association Scale (mJOA). Handa et al. 5 similarly concluded in a retrospective study of 61 patients that the duration of symptoms was not significant, but only in patients under 70. The results of these retrospective studies are supported by a prospective study of 81 patients with a mean follow-up of 10 months that found no association as assessed by mJOA and Nurick. 7 Of the studies that suggest an association between prolonged symptom duration and poor outcomes, many do not provide a clear threshold of symptom duration beyond which outcomes are significantly affected. [29] [30] [31] [32] Of those that do, 12 and 24 months are often cited. For example, in a retrospective study of 109 patients with cervical radiculopathy and 55 with cervical myelopathy, Bertalanffy 8 and Eggert found that duration of symptoms beyond 12 months significantly correlated with worse outcomes as assessed by This table summarizes the median change in Nurick score according to duration of symptoms and smoking status. Note that while there are slight differences in the median preoperative Nurick score, there was no significant influence of symptom duration or smoking status on preoperative Nurick score. The corresponding ordered logit regression coefficients and P values are displayed. Note that the duration of symptoms had a significant influence on change in Nurick score only in nonsmokers at the 24-month threshold. Nchange, change in Nurick score; Npre, preoperative Nurick.
the evaluation criteria set forth by Roosen and Grote. 33 Heidecke et al. 9 arrived at the same conclusion from a retrospective review of 106 patients using the European Myelopathy Score. In a large retrospective review of 248 patients, Pumberger et al. 11 found that patients who did not improve by at least 1 Nurick grade following surgical decompression for CSM had an average of 17.85 months of preoperative symptoms, whereas those who did improve by at least 1 Nurick grade had symptoms for an average of 11.21 months. In a prospective study of 98 patients, Suzuki et al. 10 found that the recovery rate of the JOA was significantly decreased in those with more than 1 year of preoperative symptoms. Similarly, in prospective studies using the Nurick score, both Chagas et al.
14 and Suri et al. 13 found a significant difference in outcomes in patients with more than 2 years of symptoms. Finally, in reviews of the literature, Tetreault et al. 34 found that duration of symptoms was predictive of outcomes as assessed by both mJOA and Nurick, but both Holly et al. 15 and Yoon et al. 16 found a low level of evidence for the influence of symptom duration on outcomes. 33 Our results show that smoking attenuates the benefits of early intervention. Specifically, nonsmokers showed a significant decrease in the change in Nurck score beyond 24 months. The logit regression coefficient of À2.87 indicates that patients with more than 24 months of symptoms can be modeled to have a corresponding decrease in Nurick change by 2.87 points (taking into account the ordinal nature of the Nurick scale), assuming that all other variables are constant. However, smokers showed no statistically significant association with any threshold of symptom duration, indicating that tobacco use may have such a powerfully negative influence on outcomes that it masks the effects of other factors.
These findings are consistent with previous work on the effects of tobacco use. We have previously described the harmful effects of smoking on surgical outcomes of CSM. 27 Furthermore, there is an increased risk of nonunion and poor outcomes in smokers who have undergone cervical surgery [35] [36] [37] [38] [39] and some evidence suggests that cigarette smoke is directly toxic to the spinal cord. For example, it is well known that cigarette smoke has vasoconstrictive properties and thus may contribute to spinal cord ischemia. 40 Furthermore, animal models have shown that cigarette smoke increases the permeability of the bloodspinal cord barrier, increases edema, and reduces glutathione levels. 41 Human studies have suggested that cigarette smoke may reduce the microstructural integrity of cerebral white matter 42 and at least one study has suggested that cigarette smoke itself is a risk factor for the development of CSM in genetically predisposed populations as a result of increased disc degeneration. 43 Taken together, these data are consistent with our findings that smokers had worse outcomes than nonsmokers and support potential mechanisms by which cigarette smoke may compound the injury sustained by the spinal cord during prolonged myelopathy.
There are several strengths and limitations to this study. The fact that all patients were operated on by the same surgeon minimizes variability in outcomes due to surgeon skill. We also controlled for multiple variables that are known to affect CSM outcomes, but we did not have quantitative data with respect to degree or surface area of compression nor were we able to compare results using several outcome measures such as the JOA in addition to the Nurick. Furthermore, the data regarding duration of symptoms are approximate, as patients must usually estimate the onset of myelopathic symptoms due to the insidious nature of this condition. This study also suffers from the inherent biases and shortcomings of retrospective studies, and the fact that this was not a multicenter study may limit generalizability of the results. Further work is needed to describe the influence of tobacco use on the timing of surgical decompression.
CONCLUSION
Our study demonstrates that increased duration of symptoms significantly affects outcomes in surgical decompression of CSM. Even a history of moderate to light cigarette use may attenuate the benefit of early decompression and results in lower improvement in Nurick score regardless of symptom duration.
Key Points
Previous work has suggested that longer duration of symptoms in patients with cervical myelopathy is predictive of poor outcome. In addition, it is known that smoking is universally a poor prognostic factor. Nonsmokers have a greater improvement in Nurick score than smokers. A significant difference in outcome was found at a threshold of 24 months of preoperative symptoms, but only in nonsmokers. These results suggest that, in addition to the universally negative effects of smoking on healing, smoking may also attenuate the benefits of early decompression in patients with cervical myelopathy.
